Clinical trial

Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)

NCT00651014

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2004-01-01

PhasePHASE4

Study timeline

Study start (unknown)2004-01-01Date precision: month

Registry last updated2022-02-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypercholesterolemiaunresolved

Atherosclerosisunresolved

Interventions

EzetimibeDRUG · verified · RxNorm: ezetimibe

PlaceboDRUG

Sponsors & collaborators

Organon and Colead sponsor

Merck Frosst Canada Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00651014 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.